Neuropathological alterations in Alzheimer disease

Serrano-Pozo, A., Frosch, M. P., Masliah, E., Hyman, B. T.·2011·Cold Spring Harbor Perspectives in Medicine

Cited by (1,028)

Items 501–600 of 1,028

  1. CRISPR/dCas9-Dnmt3a-mediated targeted DNA methylation of APP rescues brain pathology in a mouse model of Alzheimer’s disease
    Hanseul Park, Jaein Shin, Yun-Kyung Kim, Takashi Saito, Takaomi C. Saido, Jongpil Kim · 2022 · Translational Neurodegeneration
  2. A comprehensive assessment of resting state networks: bidirectional modification of functional integrity in cerebro-cerebellar networks in dementia
    Gloria Castellazzi, Fulvia Palesi, Stefano Casali, Paolo Vitali, Elena Sinforiani, Claudia A. M. Gandini Wheeler‐Kingshott, Egidio Ugo D'Angelo · 2014 · Frontiers in Neuroscience
  3. Migration of blood cells to β-amyloid plaques in Alzheimer's disease
    Hohsfield, Lindsay A., Humpel, Christian · 2015 · Experimental Gerontology
  4. Early Detection of Cerebral Glucose Uptake Changes in the 5XFAD Mouse
    Macdonald, I.R., DeBay, D.R., Reid, G.A., O’Leary, T.P., Jollymore, C.T., Mawko, G., Burrell, S., Martin, E., Bowen, C.V., Brown, R.E. et al. · 2014 · Current Alzheimer Research
  5. Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders
    Yazan S. Batarseh, Quoc-Viet Duong, Youssef M. Mousa, Sweilem B. Al Rihani, Khaled H. Elfakhri, Amal Kaddoumi · 2016 · International Journal of Molecular Sciences
  6. Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease‐modifying therapies
    Frisoni, Giovanni B., Molinuevo, José Luis, Altomare, Daniele, Carrera, Emmanuel, Barkhof, Frederik, Berkhof, Johannes, Delrieu, Julien, Dubois, Bruno, Kivipelto, Miia, Nordberg, Agneta et al. · 2020 · Alzheimer's & Dementia
  7. Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease
    Jessika Royea, Luqing Zhang, Xin‐Kang Tong, Édith Hamel · 2017 · Journal of Neuroscience
  8. Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer’s disease
    Tatsuhiro Terada, Joseph Therriault, Min Su Kang, Mélissa Savard, Tharick Ali Pascoal, Firoza Zubeida Lussier, Cécile Tissot, Yi-Ting Wang, Andréa Lessa Benedet, Takashi Matsudaira et al. · 2021 · Molecular Neurodegeneration
  9. Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming
    Sun, Zhao, Kwon, Ji-Sun, Ren, Yudong, Chen, Shawei, Walker, Courtney K., Lu, Xinguo, Cates, Kitra, Karahan, Hande, Sviben, Sanja, Fitzpatrick, James A. J. et al. · 2024 · Science
  10. Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease
    Xilin Wu, Juan Piña-Crespo, Yun‐wu Zhang, Xiaochun Chen, Huaxi Xu · 2017 · Chinese Medical Journal
  11. Brain organoids: a next step for humanized Alzheimer’s disease models?
    Yannis Gerakis, Claudio A. Hetz · 2019 · Molecular Psychiatry
  12. Protective effect of daidzein against streptozotocin‐induced Alzheimer's disease via improving cognitive dysfunction and oxidative stress in rat model
    Jie Wei, Fenggang Yang, Chuanbao Gong, Xingyuan Shi, Guangliang Wang · 2019 · Journal of Biochemical and Molecular Toxicology
  13. Pharmacological doses of melatonin impede cognitive decline in tau‐related Alzheimer models, once tauopathy is initiated, by restoring the autophagic flux
    Enrique Luengo, Izaskun Buendía, Cristina Fernández‐Mendívil, Paula Trigo-Alonso, Pilar Negredo, Patrycja Michalska, Borja Jesús Hernández-García, Cristina Sánchez‐Ramos, Juan Antonio Bernal, Tsuneya Ikezu et al. · 2019 · Journal of Pineal Research
  14. Neurovascular Inflammaging in Health and Disease
    Ádám Mészáros, Kinga Molnár, Bernát Nógrádi, Zsófia Hernádi, Ádám Nyúl‐Tóth, Imola Wilhelm, István Adorján Krizbai · 2020 · Cells
  15. Axonal generation of amyloid-β from palmitoylated APP in mitochondria-associated endoplasmic reticulum membranes
    Raja Bhattacharyya, Sophia E. Black, Madhura S. Lotlikar, Rebecca H. Fenn, Mehdi Jorfi, Dora M. Kovacs, Rudolph E. Tanzi · 2021 · Cell Reports
  16. Hederagenin improves Alzheimer's disease through PPARα/TFEB-mediated autophagy
    Xie, Zhi-shen, Zhao, Jian-ping, Wu, Li-min, Chu, Shuang, Cui, Zheng-hao, Sun, Yi-ran, Wang, Hui, Ma, Hui-fen, Ma, Dong-rui, Wang, Pan et al. · 2023 · Phytomedicine
  17. Long-term use of metformin and Alzheimer’s disease: beneficial or detrimental effects
    Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, ‏Hebatallah M. Saad, Gaber El‐Saber Batiha · 2023 · Inflammopharmacology
  18. Current Understanding of the Anatomy, Physiology, and Magnetic Resonance Imaging of Neurofluids: Update From the 2022 “ ISMRM Imaging Neurofluids Study group” Workshop in Rome
    Nivedita Agarwal, Laura D. Lewis, Lydiane Hirschler, Leonardo A. Rivera‐Rivera, Shinji Naganawa, Swati Rane Levendovszky, Geir André Ringstad, Marijan Klarica, Joanna Marguerite Wardlaw, Costantino Iadecola et al. · 2023 · Journal of Magnetic Resonance Imaging
  19. Endothelial Cells Are Heterogeneous in Different Brain Regions and Are Dramatically Altered in Alzheimer's Disease
    Annie G. Bryant, Zhaozhi Li, Rojashree Jayakumar, Alberto Serrano‐Pozo, Benjamin Woost, Miwei Hu, Maya E. Woodbury, Astrid Wachter, Gen Lin, Taekyung Kwon et al. · 2023 · Journal of Neuroscience
  20. Microglia and amyloid plaque formation in Alzheimer's disease – Evidence, possible mechanisms, and future challenges
    Stefanie Fruhwürth, Henrik Zetterberg, Søren R. Paludan · 2024 · Journal of Neuroimmunology
  21. Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions
    Min‐Young Noh, Hyuk Sung Kwon, Min‐Soo Kwon, Minyeop Nahm, Hee Kyung Jin, Jae‐sung Bae, Seung Hyun Kim · 2025 · Molecular Neurodegeneration
  22. In situ fibrillizing amyloid-beta 1-42 induces neurite degeneration and apoptosis of differentiated SH-SY5Y cells
    Jekaterina Krishtal, Olga Bragina, Kristel Metsla, Peep Palumaa, Vello Tõugu · 2017 · PLoS ONE
  23. Association of Aβ with ceramide-enriched astrosomes mediates Aβ neurotoxicity
    Elsherbini, Ahmed, Kirov, Alexander S., Dinkins, Michael B., Wang, Guanghu, Qin, Haiyan, Zhu, Zhihui, Tripathi, Priyanka, Crivelli, Simone M., Bieberich, Erhard · 2020 · Acta Neuropathologica Communications
  24. Age-dependent and region-specific alteration of parvalbumin neurons and perineuronal nets in the mouse cerebral cortex
    Ueno, Hiroshi, Takao, Keizo, Suemitsu, Shunsuke, Murakami, Shinji, Kitamura, Naoya, Wani, Kenta, Okamoto, Motoi, Aoki, Shozo, Ishihara, Takeshi · 2018 · Neurochemistry International
  25. Powering Amyloid Beta Degrading Enzymes: A Possible Therapy for Alzheimer’s Disease
    Nkumbu L. Sikanyika, Helena C. Parkington, A. Ian Smith, Sanjaya Kuruppu · 2019 · Neurochemical Research
  26. Gut Microbiota Disorder, Gut Epithelial and Blood–Brain Barrier Dysfunctions in Etiopathogenesis of Dementia: Molecular Mechanisms and Signaling Pathways
    Menizibeya Osain Welcome · 2019 · NeuroMolecular Medicine
  27. Quercetin Exerts Differential Neuroprotective Effects Against H2O2 and Aβ Aggregates in Hippocampal Neurons: the Role of Mitochondria
    Juan Alejandro Godoy, Carolina B. Lindsay, Rodrigo A. Quintanilla, Francisco J. Carvajal, Waldo F. Cerpa, Nibaldo C. Inestrosa · 2016 · Molecular Neurobiology
  28. Bioactive Food Abates Metabolic and Synaptic Alterations by Modulation of Gut Microbiota in a Mouse Model of Alzheimer’s Disease
    Tauqeerunnisa Syeda, Mónica Sánchez‐Tapia, Laura Pinedo‐Vargas, Omar Granados, Daniel Cuervo-Zanatta, Eleazar Rojas-Santiago, Sofía Y. Díaz-Cintra, Nimbe Torres, Claudia Perez‐Cruz · 2018 · Journal of Alzheimer s Disease
  29. Comparison of Common and Disease-Specific Post-translational Modifications of Pathological Tau Associated With a Wide Range of Tauopathies
    Fuyuki Kametani, Mari Yoshida, Tomoyasu Matsubara, Shigeo Murayama, Yuko Saito, Ito Kawakami, Mitsumoto Onaya, Hidetomo Tanaka, Akiyoshi Kakita, Andrew Robinson et al. · 2020 · Frontiers in Neuroscience
  30. The potential clinical value of plasma biomarkers in Alzheimer's disease
    Blennow, Kaj, Galasko, Douglas, Perneczky, Robert, Quevenco, Frances‐Catherine, van der Flier, Wiesje M., Akinwonmi, Akin, Carboni, Margherita, Jethwa, Alexander, Suridjan, Ivonne, Zetterberg, Henrik · 2023 · Alzheimer's & Dementia
  31. Role of purinergic receptors in the Alzheimer’s disease
    Marek Cieślak, Andrzej Wojtczak · 2018 · Purinergic Signalling
  32. The concept of resilience to Alzheimer’s Disease: current definitions and cellular and molecular mechanisms
    L. D. de Vries, I. Huitinga, Helmut W. Kessels, D. Swaab, J. Verhaagen · 2024 · Molecular Neurodegeneration
  33. The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player
    Yasmin Amy Divecha, Sanketh Rampes, Sabine Tromp, Sevda Boyanova, Alice L. Fleckney, Mehmet Fidanboylu, Sarah Ann Thomas · 2025 · Pharmacological Reviews
  34. Biophysical Alterations in Lipid Rafts from Human Cerebral Cortex Associate with Increased BACE1/AβPP Interaction in Early Stages of Alzheimer's Disease
    Mario L. Díaz, Noemí Fabelo, M.V. Martín, Isidró Ferrer, Tomás Gómez, Raquel Marín · 2014 · Journal of Alzheimer s Disease
  35. A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer’s disease mice
    Panchanan Maiti, Tia C. Hall, Leela Paladugu, Nivya Kolli, Cameron R. Learman, Julien Rossignol, Gary Leo Dunbar · 2016 · Histochemistry and Cell Biology
  36. Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and β-amyloid as an indicator of cognitive performance at high age
    Jiri M.G. Van Bergen, Xu Li, Frances C. Quevenco, Anton Franz Gietl, Valérie Treyer, Rafael Meyer, Alfred Buck, Philipp Antonio Kaufmann, Roger M. Nitsch, Peter C.M. van Zijl et al. · 2018 · NeuroImage
  37. Fluid Flow and Mass Transport in Brain Tissue
    Lori Ray, Jeffrey J. Heys · 2019 · Fluids
  38. Oxidative challenge in Alzheimer's disease: state of knowledge and future needs
    Cervellati, Carlo, Wood, Paul L, Romani, Arianna, Valacchi, Giuseppe, Squerzanti, Monica, Sanz, Juana Maria, Ortolani, Beatrice, Zuliani, Giovanni · 2016 · Journal of Investigative Medicine
  39. Procyanidins and Alzheimer’s Disease
    Siqi Zhao, Li Zhang, Chenlu Yang, Zhenghua Li, Shuang Rong · 2019 · Molecular Neurobiology
  40. Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease
    Weiwei Yu, Haiqiang Jin, Yining Huang · 2021 · Clinical Science
  41. ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer’s Disease
    Somya Patro, Sujay Ratna, Hianny A. Yamamoto, Andrew T. Ebenezer, Dillon S. Ferguson, Amanpreet Kaur, Brendan C. McIntyre, Ryan Snow, María E. Solesio · 2021 · International Journal of Molecular Sciences
  42. Transcriptomic Profiling Identifies CD8+ T Cells in the Brain of Aged and Alzheimer’s Disease Transgenic Mice as Tissue-Resident Memory T Cells
    B. Altendorfer, M. S. Unger, R. Poupardin, Anna Hoog, D. Asslaber, I. Gratz, H. Mrowetz, Ariane Benedetti, Diana M. Bessa de Sousa, R. Greil et al. · 2022 · Journal of Immunology
  43. A meta-analysis investigating the relationship between inflammation in autoimmune disease, elevated CRP, and the risk of dementia
    Joseph Cooper, Ylenia Pastorello, MARK A. SLEVIN · 2023 · Frontiers in Immunology
  44. Stem cells-derived exosomes alleviate neurodegeneration and Alzheimer’s pathogenesis by ameliorating neuroinflamation, and regulating the associated molecular pathways
    Muhammad Imran Khan, Eun Sun Jeong, Muhammad Zubair Khan, Jin Hyuk Shin, Jong Deog Kim · 2023 · Scientific Reports
  45. Tau, Glial Fibrillary Acidic Protein, and Neurofilament Light Chain as Brain Protein Biomarkers in Cerebrospinal Fluid and Blood for Diagnosis of Neurobiological Diseases
    Yongkyu Park, Nirajan KC, Alysta Paneque, Peter D. Cole · 2024 · International Journal of Molecular Sciences
  46. Transcription Factor EB Is Selectively Reduced in the Nuclear Fractions of Alzheimer’s and Amyotrophic Lateral Sclerosis Brains
    Hongjie Wang, Ruizhi Wang, Shaohua Xu, Madepalli Krishnappa Lakshmana · 2016 · Neuroscience Journal
  47. Therapeutic potential of nuclear receptor agonists in Alzheimer's disease
    Miguel Moutinho, Gary E. Landreth · 2017 · Journal of Lipid Research
  48. Sex differences in the development of mild cognitive impairment and probable Alzheimer’s disease as predicted by hippocampal volume or white matter hyperintensities
    Shanna L. Burke, Tianyan Hu, Nicole M. Fava, Tan Li, Miriam Jocelyn Rodriguez, Katie L. Schuldiner, Aaron Burgess, Angela R. Laird · 2018 · Journal of Women & Aging
  49. The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model
    Chiara Criscuolo, Elisa Cerri, Carlotta Fabiani, Simona Capsoni, Antonino Cattaneo, Luciano Domenici · 2018 · Neurobiology of Aging
  50. Proteomics of neurodegenerative diseases: analysis of human post‐mortem brain
    Ka Wan Li, Andrea B. Ganz, August Benjamin Smit · 2018 · Journal of Neurochemistry
  51. Molecular Genetics of Neurodegenerative Dementias
    Flora I. Hinz, Daniel H. Geschwind · 2016 · Cold Spring Harbor Perspectives in Biology
  52. Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex
    Sepulcre, Jorge, Grothe, Michel J., Sabuncu, Mert, Chhatwal, Jasmeer, Schultz, Aaron P., Hanseeuw, Bernard, El Fakhri, Georges, Sperling, Reisa, Johnson, Keith A. · 2017 · JAMA Neurology
  53. Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography.
    B. Janssen, D. Vugts, U. Funke, Ger T. Molenaar, P. S. Kruijer, B. N. van Berckel, A. Lammertsma, A. Windhorst · 2016 · Biochimica et Biophysica Acta
  54. eEF2K inhibition blocks Aβ42 neurotoxicity by promoting an NRF2 antioxidant response
    Asad Jan, Brandon Jansonius, Alberto Delaidelli, Syam Prakash Somasekharan, Forum Bhanshali, Milène Vandal, Gian Luca Negri, Donald G. Moerman, Ian R. Mackenzie, Frédéric Calon et al. · 2016 · Acta Neuropathologica
  55. SIRT1 facilitates amyloid beta peptide degradation by upregulating lysosome number in primary astrocytes
    Minzhe Li, Jianguo Ji, Liang-Jun Zheng, Jian Shen, Xinya Li, Qi Zhang, Xue Bai, Qingsong Wang · 2018 · Neural Regeneration Research
  56. Chronic pulmonary exposure to traffic-related fine particulate matter causes brain impairment in adult rats
    Chi-Hsiang Shih, Jen‐Kun Chen, Li‐Wei Kuo, Kuan-Hung Cho, Ta-Chih Hsiao, Zhe-Wei Lin, Yi-Syuan Lin, Jiunn‐Horng Kang, Yu‐Chun Lo, Kai-Jen Chuang et al. · 2018 · Particle and Fibre Toxicology
  57. MicroRNAs as diagnostic and therapeutic tools for Alzheimer’s disease: advances and limitations
    PhilipV Peplow, Bridget Martinez · 2018 · Neural Regeneration Research
  58. Relationship of traumatic brain injury to chronic mental health problems and dementia in military veterans
    Gregory A. Elder, Michelle E. Ehrlich, Sam Gandy · 2019 · Neuroscience Letters
  59. The potential health benefits of the isoflavone glycoside genistin
    Anowarul Islam, Md Sadikul Islam, Md Nazim Uddin, Mir Md. Iqbal Hasan, Md Rashedunnabi Akanda · 2020 · Archives of Pharmacal Research
  60. Alzheimer’s disease progression characterized by alterations in the molecular profiles and biogenesis of brain extracellular vesicles
    Xavier Gallart‐Palau, Xue Guo, Aida Serra, Siu Kwan Sze · 2020 · Alzheimer s Research & Therapy
  61. Gut microbiome-mediated epigenetic regulation of brain disorder and application of machine learning for multi-omics data analysis
    Harpreet Kaur, Yuvraj Singh, Surjeet Singh, Raja B. Singh · 2020 · Genome
  62. Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in Diabetes Mellitus and Alzheimer’s disease
    Xiao-Wen Ding, Megan Robinson, Rongzi Li, Hadeel Aldhowayan, Thangiah Geetha, Jeganathan Ramesh Babu · 2021 · Pharmacological Research
  63. Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer’s Disease: A Comprehensive Review
    Hannah Waleed Haddad, Garett W. Malone, Nicholas J. Comardelle, Arielle E. Degueure, Adam Marc Kaye, Alan D. Kaye · 2022 · Health Psychology Research
  64. Insulin and Its Key Role for Mitochondrial Function/Dysfunction and Quality Control: A Shared Link between Dysmetabolism and Neurodegeneration
    Giacoma Galizzi, Marta Di Carlo · 2022 · Biology
  65. The endoplasmic reticulum stress and unfolded protein response in Alzheimer's disease: a calcium dyshomeostasis perspective.
    D. Lim, L. Tapella, Giulia Dematteis, A. Genazzani, Marco Corazzari, A. Verkhratsky · 2023 · Ageing Research Reviews
  66. Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments
    Thaís Aparecida Sales, Ingrid G. Prandi, Alexandre Alves de Castro, Daniel Henriques Soares Leal, Elaine F. F. da Cunha, Kamil Kuča, Teodorico C. Ramalho · 2019 · International Journal of Molecular Sciences
  67. The <scp>NLRP3</scp> inflammasome modulates tau pathology and neurodegeneration in a tauopathy model
    Stancu, Ilie Cosmin, Lodder, Chritica, Botella Lucena, Pablo, Vanherle, Sarah, Gutiérrez de Ravé, Manuel, Terwel, Dick, Bottelbergs, Astrid, Dewachter, Ilse · 2022 · Glia
  68. The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer’s Disease
    Gholamreza Azizi, Shadi Sadat Navabi, Ahmed K. Al-Shukaili, Mir Hadi Seyedzadeh, Reza Yazdani, Abbas Mirshafiey · 2015 · Sultan Qaboos University medical journal
  69. Anti-Tau Trials for Alzheimer's Disease: A Report from the EU/US/CTAD Task Force
    Jeffrey L. Cummings, Kaj Blennow, Keith A. Johnson, Michael B. Keeley, Randall John Bateman, José Luís Molinuevo, Jacques Touchon, Paul S. S. Aisen, Bruno J. Vellas · 2019 · The Journal of Prevention of Alzheimer s Disease
  70. Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How
    Lewandowski, Cutler T., Maldonado Weng, Juan, LaDu, Mary Jo · 2020 · Neurobiology of Disease
  71. Noninvasive characterization of Alzheimer’s disease by circulating, cell-free messenger RNA next-generation sequencing
    Shusuke Toden, Jia-Li Zhuang, Alexander D. Acosta, Amy P. Karns, N. Salathia, J. Brewer, D. Wilcock, Jonathan Aballi, M. Nerenberg, S. Quake et al. · 2020 · Science Advances
  72. Alzheimer’s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical Models
    María José Carranza-Naval, María Vargas-Soria, Carmen Hierro‐Bujalance, Gloria Baena‐Nieto, Mónica Garcı́a-Alloza, Carmen Infante‐Garcia, Àngel del Marco · 2021 · Biomolecules
  73. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia
    Chritica Lodder, Isabelle Scheyltjens, Ilie‐Cosmin Stancu, Pablo Botella Lucena, Manuel Gutiérrez de Ravé, Sarah Vanherle, Tim Vanmierlo, Niels Cremers, Hannah Vanrusselt, Bert Brône et al. · 2021 · Acta Neuropathologica Communications
  74. Stimulus-induced gamma rhythms are weaker in human elderly with mild cognitive impairment and Alzheimer’s disease
    Dinavahi V. P. S. Murty, Keerthana Manikandan, Wupadrasta Santosh Kumar, Ranjini Garani Ramesh, Simran Purokayastha, Bhargavi Nagendra, Abhishek ML, Aditi Balakrishnan, Mahendra Javali, Naren Prahalada Rao et al. · 2021 · eLife
  75. Mitostasis, Calcium and Free Radicals in Health, Aging and Neurodegeneration
    Juan Alejandro Godoy, Juvenal A. Ríos, Pol Picón-Pagès, Víctor Herrera-Fernández, Bronte Swaby, Giulia Crepin, Rubén Vicente, José M. Fernández‐Fernández, Francisco J. Muñoz · 2021 · Biomolecules
  76. Therapeutic non-invasive brain treatments in Alzheimer’s disease: recent advances and challenges
    Chong-Yun Wu, Luo-Man Yang, Shu Feng, Ling Zhu, Luo-Dan Yang, Tim-On C. Liu, Rui Duan · 2022 · Inflammation and Regeneration
  77. Effects of ginsenoside Rg1 or 17β-estradiol on a cognitively impaired, ovariectomized rat model of Alzheimer’s disease
    Xiaodan Zhang, Jiayin Wang, Y. Xing, L. Gong, H. Li, Zhibing Wu, Y. Li, J Wang, Yan‐Jiang Wang, L. Dong et al. · 2012 · Neuroscience
  78. Alzheimer’s Disease and ncRNAs
    Rotem Maoz, Benjamin P. Garfinkel, Hermona Soreq · 2017 · Advances in experimental medicine and biology
  79. Attenuation of neurobehavioral and neurochemical abnormalities in animal model of cognitive deficits of Alzheimer’s disease by fermented soybean nanonutraceutical
    Prakash Chandra Bhatt, Shruti Pathak, Vikas Kumar, Bibhu Prasad Panda · 2017 · Inflammopharmacology
  80. Transcriptional network analysis of human astrocytic endfoot genes reveals region-specific associations with dementia status and tau pathology
    Simon, Matthew J., Wang, Marie X., Murchison, Charles F., Roese, Natalie E., Boespflug, Erin L., Woltjer, Randall L., Iliff, Jeffrey J. · 2018 · Scientific Reports
  81. Progression of Alzheimer’s disease, tau propagation, and its modifiable risk factors
    Shuko Takeda · 2018 · Neuroscience Research
  82. Pharmacological Mechanisms Underlying the Neuroprotective Effects of Alpinia oxyphylla Miq. on Alzheimer’s Disease
    Jia Feng Xu, Fang Wang, Jiejie Guo, Chunshuang Xu, Yanzi Cao, Zhiling Fang, Qinwen Wang · 2020 · International Journal of Molecular Sciences
  83. The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases
    Delsuz Rezaee, Fatemeh Saadatpour, Nayyereh Akbari, Anahita Zoghi, Sajad Najafi, Parisa Beyranvand, Fahimeh Zamani Rarani, Mohammad Amin Rashidi, Saeid Bagheri‐Mohammadi, Mohammad Bakhtiari · 2023 · Ageing Research Reviews
  84. Functionalised Carbon Nanotubes Enhance Brain Delivery of Amyloid-Targeting Pittsburgh Compound B (PiB)-Derived Ligands
    Pedro Miguel Costa, Julie T.-W. Wang, Jean‐François Morfin, Tamanna Khanum, Wan To, Jane K. Sosabowski, Éva Tóth, Khuloud T. Al‐Jamal · 2018 · Nanotheranostics
  85. Risk Factors and Pathogenesis of HIV-Associated Neurocognitive Disorder: The Role of Host Genetics
    Ian S. Olivier, Ramón Cacabelos, Vinogran Naidoo · 2018 · International Journal of Molecular Sciences
  86. Tribbles Pseudokinase 3 Induces Both Apoptosis and Autophagy in Amyloid-β-induced Neuronal Death
    Saleem, Suraiya, Biswas, Subhas Chandra · 2017 · Journal of Biological Chemistry
  87. Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease
    Haoshen Shi, Yosef Koronyo, Dieu-Trang S. Fuchs, Julia Sheyn, Kolja Wawrowsky, Shouri Lahiri, Keith L. Black, Maya Koronyo‐Hamaoui · 2020 · Acta Neuropathologica Communications
  88. EGFR is a potential dual molecular target for cancer and Alzheimer’s disease
    Hee-Jeong Choi, Yoo Joo Jeong, Jieun Kim, Hyang‐Sook Hoe · 2023 · Frontiers in Pharmacology
  89. The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
    Sriram Balusu, Bart De Strooper · 2024 · Acta Neuropathologica
  90. Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence
    Yandra Cervelim Nunes, Nathalia. M. Mendes, Enzo Pereira de Lima, Amanda Chabrour Chehadi, Caroline Barbalho Lamas, J. Haber, Manoela dos Santos Bueno, A. Araújo, Vitor C. Strozze Catharin, C. R. P. Detregiachi et al. · 2024 · Nutrients
  91. Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer’s disease, Parkinson’s disease and ischemic brain stroke: their molecular targets and action mechanisms
    Dong‐Young Choi, Hyukjae Choi · 2014 · Archives of Pharmacal Research
  92. Visual system manifestations of Alzheimer's disease
    Yael N. Kusne, Andrew B. Wolf, Kate Townley, Mandi D. Conway, Gholam A. Peyman · 2016 · Acta Ophthalmologica
  93. Wnt‐induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease
    Pedro Cisternas, Juan Manuel Zolezzi, Milka Martínez, Viviana I. Torres, Guang William Wong, Nibaldo C. Inestrosa · 2018 · Journal of Neurochemistry
  94. Tau immunotherapies for Alzheimer’s disease
    Justin L. Hoskin, Marwan Noel Sabbagh, Yazan M. Al-Hasan, Boris Decourt · 2019 · Expert Opinion on Investigational Drugs
  95. A multilevel view of the development of Alzheimer's Disease.
    J. Ávila, George Perry · 2020 · Neuroscience
  96. TREM2 alters the phagocytic, apoptotic and inflammatory response to Aβ42 in HMC3 cells
    Akhter, Rumana, Shao, Yvonne, Formica, Shane, Khrestian, Maria, Bekris, Lynn M. · 2021 · Molecular Immunology
  97. Protective Effects of Flavonoids against Alzheimer’s Disease: Pathological Hypothesis, Potential Targets, and Structure–Activity Relationship
    Jiao Li, Min Sun, Xiaodong Cui, Chen Li · 2022 · International Journal of Molecular Sciences
  98. Use of medical foods and nutritional approaches in the treatment of Alzheimer’s disease
    Papan Thaipisuttikul, James E. Galvin · 2012 · Clinical Practice
  99. Quinolinic acid injection in mouse medial prefrontal cortex affects reversal learning abilities, cortical connectivity and hippocampal synaptic plasticity
    Amira Latif‐Hernandez, Disha Shah, Tariq Ahmed, Adrian C. Lo, Zsuzsanna Callaerts‐Vegh, Annemie Van der Linden, Detlef Balschun, Rudi D’Hooge · 2016 · Scientific Reports
  100. Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer’s disease
    Borin, Mirta, Saraceno, Claudia, Catania, Marcella, Lorenzetto, Erika, Pontelli, Valeria, Paterlini, Anna, Fostinelli, Silvia, Avesani, Anna, Di Fede, Giuseppe, Zanusso, Gianluigi et al. · 2018 · Acta Neuropathologica Communications